Therapeutic Translation in the Wake of the Genome

Manuel Ignacio Hermosilla, Jorge Lemus

Research output: Working paper

Abstract

The completion of the Human Genome Project (“HGP”) led many scientists to predict a swift revolution in human therapeutics. Despite large advances, however, this revolution has been slow to materialize. We investigate the hypothesis that this slow progress may stem from the large amounts of biological complexity unveiled by the Genome. Our test relies on a disease-specific measure of biological complexity, constructed by drawing on insights from Network Medicine (Barabasi et al., 2011). According to this measure, more complex diseases are those associated with a larger number of genetic associations, or with higher centrality in the Human Disease Network (Goh et al., 2007). With this measure in hand, we estimate the rate of translation of new science into early stage drug innovation by focusing on a leading type of genetic epidemiological knowledge (Genome-Wide Association Studies), and employing standard methods for the measurement of R&D productivity. For less complex diseases, we find a strong and positive association between cumulative knowledge and the amount of innovation. This association weakens as complexity increases, becoming statistically insignificant at the extreme. Our results therefore suggest that biological complexity is in part responsible for the slower-than-expected unfolding of the therapeutical revolution set in motion by the HGP.
Original languageEnglish (US)
Number of pages43
StatePublished - Nov 1 2017

Publication series

NameNBER Working Paper
No.w23989

Fingerprint

genome
wakes
productivity
medicine
stems
drugs
estimates

Cite this

Hermosilla, M. I., & Lemus, J. (2017). Therapeutic Translation in the Wake of the Genome. (NBER Working Paper; No. w23989).

Therapeutic Translation in the Wake of the Genome. / Hermosilla, Manuel Ignacio; Lemus, Jorge.

2017. (NBER Working Paper; No. w23989).

Research output: Working paper

Hermosilla, MI & Lemus, J 2017 'Therapeutic Translation in the Wake of the Genome' NBER Working Paper, no. w23989.
Hermosilla MI, Lemus J. Therapeutic Translation in the Wake of the Genome. 2017 Nov 1. (NBER Working Paper; w23989).
Hermosilla, Manuel Ignacio ; Lemus, Jorge. / Therapeutic Translation in the Wake of the Genome. 2017. (NBER Working Paper; w23989).
@techreport{054ee20af2694932be7c14839e7fbbea,
title = "Therapeutic Translation in the Wake of the Genome",
abstract = "The completion of the Human Genome Project (“HGP”) led many scientists to predict a swift revolution in human therapeutics. Despite large advances, however, this revolution has been slow to materialize. We investigate the hypothesis that this slow progress may stem from the large amounts of biological complexity unveiled by the Genome. Our test relies on a disease-specific measure of biological complexity, constructed by drawing on insights from Network Medicine (Barabasi et al., 2011). According to this measure, more complex diseases are those associated with a larger number of genetic associations, or with higher centrality in the Human Disease Network (Goh et al., 2007). With this measure in hand, we estimate the rate of translation of new science into early stage drug innovation by focusing on a leading type of genetic epidemiological knowledge (Genome-Wide Association Studies), and employing standard methods for the measurement of R&D productivity. For less complex diseases, we find a strong and positive association between cumulative knowledge and the amount of innovation. This association weakens as complexity increases, becoming statistically insignificant at the extreme. Our results therefore suggest that biological complexity is in part responsible for the slower-than-expected unfolding of the therapeutical revolution set in motion by the HGP.",
author = "Hermosilla, {Manuel Ignacio} and Jorge Lemus",
year = "2017",
month = "11",
day = "1",
language = "English (US)",
series = "NBER Working Paper",
number = "w23989",
type = "WorkingPaper",

}

TY - UNPB

T1 - Therapeutic Translation in the Wake of the Genome

AU - Hermosilla, Manuel Ignacio

AU - Lemus, Jorge

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The completion of the Human Genome Project (“HGP”) led many scientists to predict a swift revolution in human therapeutics. Despite large advances, however, this revolution has been slow to materialize. We investigate the hypothesis that this slow progress may stem from the large amounts of biological complexity unveiled by the Genome. Our test relies on a disease-specific measure of biological complexity, constructed by drawing on insights from Network Medicine (Barabasi et al., 2011). According to this measure, more complex diseases are those associated with a larger number of genetic associations, or with higher centrality in the Human Disease Network (Goh et al., 2007). With this measure in hand, we estimate the rate of translation of new science into early stage drug innovation by focusing on a leading type of genetic epidemiological knowledge (Genome-Wide Association Studies), and employing standard methods for the measurement of R&D productivity. For less complex diseases, we find a strong and positive association between cumulative knowledge and the amount of innovation. This association weakens as complexity increases, becoming statistically insignificant at the extreme. Our results therefore suggest that biological complexity is in part responsible for the slower-than-expected unfolding of the therapeutical revolution set in motion by the HGP.

AB - The completion of the Human Genome Project (“HGP”) led many scientists to predict a swift revolution in human therapeutics. Despite large advances, however, this revolution has been slow to materialize. We investigate the hypothesis that this slow progress may stem from the large amounts of biological complexity unveiled by the Genome. Our test relies on a disease-specific measure of biological complexity, constructed by drawing on insights from Network Medicine (Barabasi et al., 2011). According to this measure, more complex diseases are those associated with a larger number of genetic associations, or with higher centrality in the Human Disease Network (Goh et al., 2007). With this measure in hand, we estimate the rate of translation of new science into early stage drug innovation by focusing on a leading type of genetic epidemiological knowledge (Genome-Wide Association Studies), and employing standard methods for the measurement of R&D productivity. For less complex diseases, we find a strong and positive association between cumulative knowledge and the amount of innovation. This association weakens as complexity increases, becoming statistically insignificant at the extreme. Our results therefore suggest that biological complexity is in part responsible for the slower-than-expected unfolding of the therapeutical revolution set in motion by the HGP.

M3 - Working paper

T3 - NBER Working Paper

BT - Therapeutic Translation in the Wake of the Genome

ER -